Prolactin-sparing antipsychotic drugs reduce pituitary volume more than prolactin-enhancing antipsychotic drugs in chronic schizophrenia (Klomp et al., 2012, Takahashi et al., 2012). This evidence concerns the gene PRL and schizophrenia.